View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.
Get connected with journalists todayJeffrey E. Lancet
Verified
Contributor, Leukemia
Tampa
Beats
Biography
Final Covers
Health/wellness, pregnancy technology, parenting women in STEM, teens special needs, college
Doesn’t Cover
Music, Sports
Journalist Type
Seniority Positions
Industries
Medium Formats
Content
Total articles 16
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
By Christopher Dukes, Jeffrey E. Lancet, Barbara J. Kuter, Marine Potez
Dec. 21, 2023
By Qianxing Mo, Seongseok Yun, David A Sallman, Jeffrey E. Lancet
May. 08, 2023
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
By Christopher Dukes, Jeffrey E. Lancet, Barbara J. Kuter, Marine Potez
Dec. 21, 2023
As seen in
Company Info
Leukemia
The Leukemia & Lymphoma Society (LLS) is a leading organization dedicated to fighting blood cancers, including leukemia, lymphoma, Hodgkin's disease, and myeloma. Founded in 1949 and headquartered in the United States, LLS operates regional offices across North America. Its mission focuses on curing these diseases and enhancing the quality of life for patients and their families. LLS provides a wide range of services, including funding for blood cancer research, which totals nearly $1.8 billion. The organization offers free information, education, and personalized support to help patients navigate their treatment options. Additionally, LLS advocates for policies that increase research funding and improve access to therapies. It also provides educational resources and financial assistance to help patients manage the costs associated with cancer treatment. Through its efforts, LLS significantly impacts the lives of patients and families affected by blood cancers.
Tampa, , United States
+1 914-949-5213
Founded: 1949